11/24
09:40 am
rare
Rating for RARE
Low
Report
Rating for RARE
11/24
09:40 am
rare
Rating for RARE
Low
Report
Rating for RARE
10/20
08:14 am
rare
Ultragenyx Pharmaceutical (NASDAQ:RARE) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $65.00 price target on the stock.
Medium
Report
Ultragenyx Pharmaceutical (NASDAQ:RARE) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $65.00 price target on the stock.
9/9
08:07 am
rare
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.
Low
Report
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $80.00 price target on the stock.